Delivery Order SPE2DB20D2104-SPE2DB23FT42N
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,295.59, is for the delivery of NASCOBAL 500 MCG nasal sprays. It is a Firm Fixed Price delivery order contract with an ultimate completion date of September 14, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,151.58 firm fixed-price delivery order covers the supply of 4555128115 - NASCOBAL 500 MCG NASAL SPRAYS. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,710.28 Firm Fixed Price Delivery Order is for the supply of 4554939940 NASCOBAL 500 MCG NASAL SPRAYS. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,943.89 firm fixed-price delivery order is for the supply of NASCOBAL 500 MCG nasal sprays. The award was made under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,170.35 firm fixed-price delivery order is for the supply of NASCOBAL 500 MCG NASAL SPRAYS. The award has an ultimate completion date of August 9, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,300.32 firm fixed-price contract is for the delivery of 4559909224 NASCOBAL 500 MCG nasal sprays, with a completion date of February 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This federal contract award is for the delivery of Nascobal 500 mcg nasal sprays to the Defense Logistics Agency (DLA). The $2,957.38 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies, including...
- This federal contract award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $5,665.28 and an ultimate completion date of November 24, 2021. The award was made on November 23, 2021, and there was no set-aside designation....
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at $999,999,999. The contract covers a wide range of essential pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. This order, valued at $75,725.97, does not...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT42NDelivery Order
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at $999,999,999. The award, valued at $2,708.44, is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to support federal healthcare programs. Amerisourcebergen has extensive experience providing a broad range of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense and Department of Veterans Affairs. This contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen's position as a prime contractor on this DLA Troop Support Medical Indefinite Delivery Contract, as well as a separate contract with the Department of Justice Federal Bureau of Investigation, demonstrates its importance as a key vendor for essential medical commodities across various federal agencies and healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 5/8/23 |